Targeted radiation for ventricular tachycardia
Part of Heart & circulation clinical trials.
This trial studies a new way to treat a dangerous fast heart rhythm (ventricular tachycardia) using targeted radiation to the heart. It is for people who have already tried other treatments and are still having symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years of age or older.
- You have an implanted defibrillator (a device that monitors and corrects your heart rhythm).
- You have had a specific type of fast heart rhythm (ventricular tachycardia) at least twice in the last 8 weeks, or you have had a 'storm' of these episodes.
- Your heart's pumping strength is at least 20% (you have enough heart function).
- You have had at least one prior heart ablation, and medications have not controlled your fast heart rhythm.
- You have not had radiation to the chest or upper belly before, and you do not have a lung condition called interstitial lung disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a radiation approach (called stereotactic body radiation therapy, or SBRT) to treat ventricular tachycardia (a dangerous heart rhythm) that keeps coming back. It aims to reduce the rhythm episodes in people who have already tried catheter ablation (a procedure to cauterize rhythm sources) or cannot have it.
This study looks at using SBRT (high-precision radiation) to treat a dangerous, steady heart rhythm called monomorphic VT. It is meant for people who keep having VT even after prior ablation attempts and after trying a class III “rhythm-stabilizing” medicine.
This trial compares two treatments—radiation therapy or catheter ablation—for people with structural heart disease who have a type of fast heart rhythm called ventricular tachycardia. It aims to see which approach works better to prevent repeat episodes.
This study tests a targeted form of radiation therapy to stop a dangerous, repeat heart rhythm called ventricular tachycardia. It’s for people whose rhythm keeps coming back even after standard treatments like antiarrhythmic medications and prior heart procedure studies.
This Phase 2 study tests a precise form of radiation therapy to control recurrent ventricular tachycardia (VT), a dangerous fast heart rhythm. It may help people whose VT keeps coming back despite heart medicines and/or ablation, especially when ablation is not possible.
This trial tests whether a single session of targeted radiation (radioablation) is as effective as three sessions for treating a dangerous heart rhythm called ventricular tachycardia in people with heart muscle disease. It's for those who continue to have episodes despite medication and catheter ablation.
Hear when a new Ventricular Tachycardia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.